| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -71.0% | n/a |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 1.8 | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | -23.1% | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 5.12 | 0.12 | 0.02p | 256.3 | n/a | -80% | n/a | 0.0% |
| 31-Dec-22 | 7.78 | 1.25 | 0.45p | 7.8 | 0.0 | +2,150% | n/a | 0.0% |
| 31-Dec-23 | 5.03 | (2.42) | (0.83)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 4.89 | (3.25) | (1.15)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 3.76 | (3.59) | (1.04)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Appointment of Non-Executive Director | 16-Sep-2026 | 07:01 | RNS |
| Interim Results H1 2026 | 16-Sep-2026 | 07:00 | RNS |
| Further GCLP Chemoproteomics contract secured | 15-Sep-2026 | 09:24 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 1.50p |
| Change Today | 0.015p |
| % Change | 1.01 % |
| 52 Week High | 3.51 |
| 52 Week Low | 1.27 |
| Volume | 63,616 |
| Shares Issued | 350.72m |
| Market Cap | £5.24m |
| RiskGrade | 353 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:23 | 205 @ 1.30p |
| 09:07 | 63,038 @ 1.58p |
| 08:12 | 114 @ 1.69p |
| 08:12 | 200 @ 1.27p |
| 08:12 | 59 @ 1.69p |
You are here: research